Latest News
Fermenta Biotech Limited

Fermenta Biotech Limited & Indchemie Health Specialities Pledge Vitamin D3 to 250,000 Maharashtra Police Personnel for 2 Months

“Help protect our protectors” initiative to support the immunity of Corona Warriors

Jun 16, 2020 11:30 IST 
Mumbai, Maharashtra, India

Fermenta Biotech Limited and Indchemie Health Specialities Private Limited have jointly committed to supplying Maharashtra Police personnel 250,000 strips of DV 60K®, each strip containing sufficient dosage for an individual’s recommended regime of 60,000 IU of Vitamin D3 per week for two months.

 

L-R: Mr. Ganesh Kute, General Manager - Marketing, Indchemie Health Specialities Private Limited, Mr. Ratan Shahi, Vice President - Commercial, Indchemie Health Specialities Private Limited, Mr. Anand Ramaswamy, Executive Director, Indchemie Health Specialities Private Limited, Mr. Krishna Prakash, IPS, Spl. Inspector General of Police (Admin), Maharashtra State
 

Around 90% of the Indian population suffers from low levels of Vitamin D, a vital nutrient with documented evidence for its important role in enhancing immunity as well as reducing the incidence, severity and risk of flu-like illness and pneumonia.

 

An initiative to Help protect our protectors with better Health and nutrition

 

The initiative will be a part of the Joint Corporate Social Responsibility programme of Fermenta, India’s only manufacturer of Vitamin D3 and a leading player globally along with Indchemie, one of the pioneers in the Indian pharmaceutical industry and the first to launch Vitamin D3 in India in soft gelatin capsules.

 

    Mr. Krishna Datla, Managing Director, Fermenta Biotech Limited

Commenting on the initiative, Mr. Krishna Datla, Managing Director, Fermenta Biotech Limited said, “We, at Fermenta, are proud of our Corona Warriors including Maharashtra Police fraternity, who are at the frontline of the battle against COVID-19. Through this initiative, we hope to thank them for their relentless efforts to protect us every day. Now, more than ever, is the time to develop a resilient community and emerge stronger, together.

 

Mr. M K Singh, Managing Director, Indchemie Health Specialities Private Limited, commented, “Indchemie is extremely proud to associate with this noble cause. We are extremely happy to partner with Fermenta to enable the Maharashtra Police personnel to build their immunity & combat COVID-19. We take this as an opportunity to express our gratitude to the Police Force, our unsung heroes & our Protectors. Indchemie is proud that our products are helping millions of people, both within the country and abroad, to lead a healthier life.

 

Mr. Krishna Prakash IPS, Spl. Inspector General of Police (Admn), Maharashtra State, commented, “Maharashtra Police highly appreciates this gesture to support our police forces in their daily battle against COVID-19. The Vitamin D provided to us will aid our colleagues to maintain their health, which is a major concern in this pandemic. Once again, we thank Fermenta and Indchemie for enabling us in our collective fight against COVID-19.”

 

About Fermenta Biotech Limited (FBL)

Fermenta Biotech Limited (FBL) is one of the leading manufacturers of Vitamin D3 globally. It caters to over 300 customers across 50 countries with a worldwide distribution network for a variety of applications such as pharmaceuticals, dietary and nutritional supplements, food, animal nutrition and rodenticides. FBL's manufacturing facilities in Kullu and Dahej are certificated by global accreditations and its world class R&D centre is located at Thane. Apart from Vitamin D3, FBL also possesses expertise in integrated biotechnology solutions such as enzymes for antibiotic synthesis and other niche APIs.

 

For more information about the Company and its businesses, please visit our website www.fermentabiotech.com

 

About Indchemie Health Specialities Private Limited

Indchemie Health Specialities Private Limited has been in the ethical pharma business for more than three decades now, with leadership in few of the segments. It has a strong back up of in-house manufacturing facility & has five Pharmaceuticals Manufacturing Units (Two at Daman, one at Baddi, Himachal Pradesh & two at Sikkim) in India.

 

Indchemie is one of the fastest growing pharma companies in India and having international presence in more than 25 countries. Indchemie today markets more than 250 products & has a workforce of more than 3500 persons.

 

For more information, please visit us at www.indchemie.in.

 

Brief Profile - Mr. Krishna Datla, MD FBL

Mr. Krishna Datla – Managing Director Mr. Krishna Datla is the Managing Director of Fermenta Biotech Limited (FBL). Krishna took over the reigns of the company from his father, the late Mr. Vasant Kumar Datla, at a young age of 24 years. He has played a key role in the development and growth of FBL’s diversified businesses. He has been credited with the integration of businesses across the various group companies, infusing a strong sense of global vision, thereby capitalizing on opportunities across international markets including highly regulated destinations. Krishna was instrumental in streamlining and improving the human resources, sales, marketing and client acquisition processes within the organization. He brought in a highly skilled leadership team and also enhanced the overall landscape of the infrastructure, product as well as service capabilities, thus strengthening the approach and outlook for the future. He is a Commerce Graduate from Mumbai University.

 

Safe Harbour

Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential project characteristics, project potential and target dates for project related issues are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. The company assumes no obligation to update forward-looking statements to reflect actual results changed assumptions or other factors.


 
 
L-R: Mr. Ganesh Kute, General Manager - Marketing, Indchemie Health Specialities Private Limited, Mr. Ratan Shahi, Vice President - Commercial, Indchemie Health Specialities Private Limited, Mr. Anand Ramaswamy, Executive Director, Indchemie Health Specialities Private Limited, Mr. Krishna Prakash, IPS, Spl. Inspector General of Police (Admin), Maharashtra State
 

Mr. Srikant Sharma, Group Company Secretary and Vice President - Legal, Fermenta Biotech Limited, Mr. Kushal Kamat, Manager - Marketing, Fermenta Biotech Limited
L-R: Mr. Ganesh Kute, General Manager - Marketing, Indchemie Health Specialities Private Limited, Mr. Ratan Shahi, Vice President - Commercial, Indchemie Health Specialities Private Limited, Mr. Anand Ramaswamy, Executive Director, Indchemie Health Specialities Private Limited, Mr. Krishna Prakash, IPS, Spl. Inspector General of Police (Admin), Maharashtra State Mr. Srikant Sharma, Group Company Secretary and Vice President - Legal, Fermenta Biotech Limited, Mr. Kushal Kamat, Manager - Marketing, Fermenta Biotech Limited
An initiative to Help protect our protectors with better Health and nutrition
An initiative to Help protect our protectors with better Health and nutrition
Mr. Krishna Datla, Managing Director, Fermenta Biotech Limited

Mr. Krishna Datla, Managing Director, Fermenta Biotech Limited
For press background on Fermenta Biotech Limited

click here
 
zlibrary project The newest online casino offers an exciting range of innovative games and features for players. z-library zlibrary project